$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2 원문보기

PLoS ONE, v.16 no.8, 2021년, pp.e0256646 -   

Nagar, Harsha (Department of Physiology and Medical Science, School of Medicine, Chungnam National University, Daejeon, Republic of Korea) ,  Kim, Seonhee (Department of Physiology and Medical Science, School of Medicine, Chungnam National University, Daejeon, Republic of Korea) ,  Lee, Ikjun (Department of Physiology and Medical Science, School of Medicine, Chungnam National University, Daejeon, Republic of Korea) ,  Choi, Su-Jeong (Department of Physiology and Medical Science, School of Medicine, Chungnam National University, Daejeon, Republic of Korea) ,  Piao, Shuyu (Department of Physiology and Medical Science, School of Medicine, Chungnam National University, Daejeon, Republic of Korea) ,  Jeon, Byeong Hwa (Department of Physiology and Medical Science, School of Medicine, Chungnam National University, Daejeon, Republic of Korea) ,  Shong, Minho (Research Center for Endocrine and Metabolic Diseases, School of Medicine, Chungnam National University, Daejeon, Republic of Korea) ,  Kim, Cuk-Seong (Department of Physiology and Medical Science, School of Medicine, Chungnam National University, Daejeon, Republic of)

Abstract AI-Helper 아이콘AI-Helper

Rho GDP-dissociation inhibitor (RhoGDI), a downregulator of Rho family GTPases, prevents nucleotide exchange and membrane association. It is responsible for the activation of Rho GTPases, which regulate a variety of cellular processes, such as migration. Although RhoGDI2 has been identified as a tum...

참고문헌 (65)

  1. 1 Trepat X. , Chen Z. , and Jacobson K. , Cell migration . Compr Physiol , 2012 . 2 ( 4 ): p. 2369 – 92 . doi: 10.1002/cphy.c110012 23720251 

  2. 2 Nobes C.D. and Hall A. , Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia . Cell , 1995 . 81 ( 1 ): p. 53 – 62 . doi: 10.1016/0092-8674(95)90370-4 7536630 

  3. 3 Scherle P. , Behrens T. , and Staudt L.M. , Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes . Proc Natl Acad Sci U S A , 1993 . 90 ( 16 ): p. 7568 – 72 . doi: 10.1073/pnas.90.16.7568 8356058 

  4. 4 Gildea J.J. , et al ., RhoGDI2 is an invasion and metastasis suppressor gene in human cancer . Cancer Res , 2002 . 62 ( 22 ): p. 6418 – 23 . 12438227 

  5. 5 Theodorescu D. , et al ., Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer . Clin Cancer Res , 2004 . 10 ( 11 ): p. 3800 – 6 . doi: 10.1158/1078-0432.CCR-03-0653 15173088 

  6. 6 Niu H. , et al ., RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway . Tumour Biol , 2015 . 36 ( 1 ): p. 409 – 19 . doi: 10.1007/s13277-014-2671-9 25266803 

  7. 7 Xia B. and Wang J. , Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression. Drug Des Devel Ther , 2019 . 13 : p. 3837 – 3844 . doi: 10.2147/DDDT.S219028 32109988 

  8. 8 Ross R. , Atherosclerosis—an inflammatory disease . N Engl J Med , 1999 . 340 ( 2 ): p. 115 – 26 . doi: 10.1056/NEJM199901143400207 9887164 

  9. 9 Kitamura K. , et al ., Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma . Biochem Biophys Res Commun , 1993 . 192 ( 2 ): p. 553 – 60 . doi: 10.1006/bbrc.1993.1451 8387282 

  10. 10 Abe M. , et al ., Adrenomedullin augments collateral development in response to acute ischemia . Biochem Biophys Res Commun , 2003 . 306 ( 1 ): p. 10 – 5 . doi: 10.1016/s0006-291x(03)00903-3 12788059 

  11. 11 Kato K. , et al ., Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion . Am J Physiol Heart Circ Physiol , 2003 . 285 ( 4 ): p. H1506 – 14 . doi: 10.1152/ajpheart.00270.2003 12805025 

  12. 12 Isumi Y. , et al ., Adrenomedullin suppresses interleukin-1beta-induced tumor necrosis factor-alpha production in Swiss 3T3 cells . FEBS Lett , 1999 . 463 ( 1–2 ): p. 110 – 4 . doi: 10.1016/s0014-5793(99)01615-4 10601648 

  13. 13 Shimosawa T. , et al ., Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage . Circulation , 2002 . 105 ( 1 ): p. 106 – 11 . doi: 10.1161/hc0102.101399 11772884 

  14. 14 Nishikimi T. and Matsuoka H. , Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure . Curr Med Chem Cardiovasc Hematol Agents , 2005 . 3 ( 3 ): p. 231 – 42 . doi: 10.2174/1568016054368241 15974887 

  15. 15 Petrie M.C. , et al ., Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans . J Hypertens , 2000 . 18 ( 1 ): p. 61 – 4 . doi: 10.1097/00004872-200018010-00009 10678544 

  16. 16 Samson W.K. , Murphy T. , and Schell D.A. , A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release . Endocrinology , 1995 . 136 ( 5 ): p. 2349 – 52 . doi: 10.1210/endo.136.5.7720684 7720684 

  17. 17 Shimosawa T. , et al ., Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress . Hypertension , 2003 . 41 ( 5 ): p. 1080 – 5 . doi: 10.1161/01.HYP.0000066846.46422.2C 12668590 

  18. 18 Xian X. , et al ., Vasoprotective Activities of the Adrenomedullin-RAMP2 System in Endothelial Cells . Endocrinology , 2017 . 158 ( 5 ): p. 1359 – 1372 . doi: 10.1210/en.2016-1531 28324104 

  19. 19 Fernandez-Sauze S. , et al ., Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors . Int J Cancer , 2004 . 108 ( 6 ): p. 797 – 804 . doi: 10.1002/ijc.11663 14712479 

  20. 20 Roh J. , et al ., Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes . J Biol Chem , 2004 . 279 ( 8 ): p. 7264 – 74 . doi: 10.1074/jbc.M305332200 14615490 

  21. 21 Morimoto R. , et al ., Expression of adrenomedullin2/intermedin in human brain , heart, and kidney. Peptides , 2007 . 28 ( 5 ): p. 1095 – 103 . doi: 10.1016/j.peptides.2007.01.018 

  22. 22 Bell D. and McDermott B.J. , Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems. Br J Pharmacol , 2008 . 153 Suppl 1 : p. S247 – 62 . doi: 10.1038/sj.bjp.0707494 17965749 

  23. 23 Cantley L.C. , The phosphoinositide 3-kinase pathway . Science , 2002 . 296 ( 5573 ): p. 1655 – 7 . doi: 10.1126/science.296.5573.1655 12040186 

  24. 24 Manning B.D. and Cantley L.C. , AKT/PKB signaling: navigating downstream . Cell , 2007 . 129 ( 7 ): p. 1261 – 74 . doi: 10.1016/j.cell.2007.06.009 17604717 

  25. 25 Ichiki T. , Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both ? Arterioscler Thromb Vasc Biol , 2006 . 26 ( 3 ): p. 449 – 55 . doi: 10.1161/01.ATV.0000196747.79349.d1 16293792 

  26. 26 Du K. and Montminy M. , CREB is a regulatory target for the protein kinase Akt/PKB . J Biol Chem , 1998 . 273 ( 49 ): p. 32377 – 9 . doi: 10.1074/jbc.273.49.32377 9829964 

  27. 27 Chung H.K. , et al ., CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle . J Biol Chem , 2003 . 278 ( 30 ): p. 28079 – 88 . doi: 10.1074/jbc.M212835200 12716909 

  28. 28 Ran Q. , et al ., CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cells . PLoS One , 2014 . 9 ( 2 ): p. e85328 . doi: 10.1371/journal.pone.0085328 24520316 

  29. 29 Kang H.J. , et al ., CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasome-mediated degradation. J Biol Chem , 2010 . 285 ( 28 ): p. 21258 – 68 . doi: 10.1074/jbc.M109.084590 20427290 

  30. 30 Park K.C. , et al ., CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation . Mol Endocrinol , 2005 . 19 ( 1 ): p. 12 – 24 . doi: 10.1210/me.2004-0107 15459248 

  31. 31 Kwon M.C. , et al ., Crif1 is a novel transcriptional coactivator of STAT3 . EMBO J , 2008 . 27 ( 4 ): p. 642 – 53 . doi: 10.1038/sj.emboj.7601986 18200042 

  32. 32 Kim S.J. , et al ., CRIF1 is essential for the synthesis and insertion of oxidative phosphorylation polypeptides in the mammalian mitochondrial membrane . Cell Metab , 2012 . 16 ( 2 ): p. 274 – 83 . doi: 10.1016/j.cmet.2012.06.012 22819524 

  33. 33 Nagar H. , et al ., CR6-Interacting Factor 1 Deficiency Impairs Vascular Function by Inhibiting the Sirt1-Endothelial Nitric Oxide Synthase Pathway . Antioxid Redox Signal , 2017 . 27 ( 4 ): p. 234 – 249 . doi: 10.1089/ars.2016.6719 28117598 

  34. 34 Takaishi K. , et al ., Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility. Mol Cell Biol , 1993 . 13 ( 1 ): p. 72 – 9 . doi: 10.1128/mcb.13.1.72-79.1993 8417362 

  35. 35 Harding M.A. and Theodorescu D. , RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation . Urol Oncol , 2007 . 25 ( 5 ): p. 401 – 6 . doi: 10.1016/j.urolonc.2007.05.006 17826660 

  36. 36 Yi M.H. , et al ., RhoGDI2 expression in astrocytes after an excitotoxic lesion in the mouse hippocampus . Cell Mol Neurobiol , 2015 . 35 ( 2 ): p. 167 – 74 . doi: 10.1007/s10571-014-0108-z 25274045 

  37. 37 Heo J. and Campbell S.L. , Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases . J Biol Chem , 2005 . 280 ( 35 ): p. 31003 – 10 . doi: 10.1074/jbc.M504768200 15994296 

  38. 38 Heo J. and Campbell S.L. , Superoxide anion radical modulates the activity of Ras and Ras-related GTPases by a radical-based mechanism similar to that of nitric oxide . J Biol Chem , 2005 . 280 ( 13 ): p. 12438 – 45 . doi: 10.1074/jbc.M414282200 15684418 

  39. 39 Ferro E. , et al ., The Interplay between ROS and Ras GTPases: Physiological and Pathological Implications. J Signal Transduct , 2012 . 2012 : p. 365769 . doi: 10.1155/2012/365769 22175014 

  40. 40 Cheung M. and Testa J.R. , Diverse mechanisms of AKT pathway activation in human malignancy . Curr Cancer Drug Targets , 2013 . 13 ( 3 ): p. 234 – 44 . doi: 10.2174/1568009611313030002 23297823 

  41. 41 Niu H. , et al ., Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis . Oncol Rep , 2010 . 24 ( 2 ): p. 465 – 71 . doi: 10.3892/or_00000880 20596634 

  42. 42 Johannessen M. , Delghandi M.P. , and Moens U. , What turns CREB on? Cell Signal , 2004 . 16 ( 11 ): p. 1211 – 27 . doi: 10.1016/j.cellsig.2004.05.001 15337521 

  43. 43 McLatchie L.M. , et al ., RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor . Nature , 1998 . 393 ( 6683 ): p. 333 – 9 . doi: 10.1038/30666 9620797 

  44. 44 Hirose T. , et al ., Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure . Eur J Heart Fail , 2008 . 10 ( 9 ): p. 840 – 9 . doi: 10.1016/j.ejheart.2008.06.020 18692436 

  45. 45 Pan C.S. , et al ., Adrenomedullin ameliorates the development of atherosclerosis in apoE-/- mice . Peptides , 2010 . 31 ( 6 ): p. 1150 – 8 . doi: 10.1016/j.peptides.2010.03.005 20332006 

  46. 46 Zeng Q. , et al ., Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rats . Peptides , 2009 . 30 ( 2 ): p. 391 – 9 . doi: 10.1016/j.peptides.2008.10.021 19041918 

  47. 47 Kitamura K. , et al ., Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. 1993 . Biochem Biophys Res Commun , 2012 . 425 ( 3 ): p. 548 – 55 . doi: 10.1016/j.bbrc.2012.08.022 22925672 

  48. 48 Nishimatsu H. , et al ., Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta . Circ Res , 2001 . 89 ( 1 ): p. 63 – 70 . doi: 10.1161/hh1301.092498 11440979 

  49. 49 Miyashita K. , et al ., Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo . FEBS Lett , 2003 . 544 ( 1–3 ): p. 86 – 92 . doi: 10.1016/s0014-5793(03)00484-8 12782295 

  50. 50 Morales-Ruiz M. , et al ., Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt . Circ Res , 2000 . 86 ( 8 ): p. 892 – 6 . doi: 10.1161/01.res.86.8.892 10785512 

  51. 51 Dimmeler S. and Zeiher A.M. , Akt takes center stage in angiogenesis signaling . Circ Res , 2000 . 86 ( 1 ): p. 4 – 5 . doi: 10.1161/01.res.86.1.4 10625297 

  52. 52 Van Aelst L. and D’Souza-Schorey C. , Rho GTPases and signaling networks . Genes Dev , 1997 . 11 ( 18 ): p. 2295 – 322 . doi: 10.1101/gad.11.18.2295 9308960 

  53. 53 Cho H.J. , Baek K.E. , and Yoo J. , RhoGDI2 as a therapeutic target in cancer . Expert Opin Ther Targets , 2010 . 14 ( 1 ): p. 67 – 75 . doi: 10.1517/14728220903449251 20001211 

  54. 54 Said N. and Theodorescu D. , RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment . Oncoimmunology , 2012 . 1 ( 7 ): p. 1175 – 1177 . doi: 10.4161/onci.20594 23170270 

  55. 55 Ma L. , et al ., Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma . Br J Haematol , 2007 . 139 ( 2 ): p. 217 – 23 . doi: 10.1111/j.1365-2141.2007.06782.x 17897297 

  56. 56 Stevens E.V. , et al ., RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis. Small GTPases , 2011 . 2 ( 4 ): p. 202 – 210 . doi: 10.4161/sgtp.2.4.17795 22145092 

  57. 57 Hinson J.P. , Kapas S. , and Smith D.M. , Adrenomedullin, a multifunctional regulatory peptide . Endocr Rev , 2000 . 21 ( 2 ): p. 138 – 67 . doi: 10.1210/edrv.21.2.0396 10782362 

  58. 58 Sexton P.M. , et al ., Receptor activity modifying proteins . Cell Signal , 2001 . 13 ( 2 ): p. 73 – 83 . doi: 10.1016/s0898-6568(00)00143-1 11257451 

  59. 59 Hamid S.A. and Baxter G.F. , Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction . Pharmacol Ther , 2005 . 105 ( 2 ): p. 95 – 112 . doi: 10.1016/j.pharmthera.2004.08.012 15670621 

  60. 60 Ishimitsu T. , et al ., Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders . Pharmacol Ther , 2006 . 111 ( 3 ): p. 909 – 27 . doi: 10.1016/j.pharmthera.2006.02.004 16616959 

  61. 61 Quadros H.C. , et al ., Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis . Int J Pharm , 2020 . 576 : p. 118997 . doi: 10.1016/j.ijpharm.2019.118997 31893542 

  62. 62 Nikitenko L.L. , et al ., Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium . Mol Hum Reprod , 2000 . 6 ( 9 ): p. 811 – 9 . doi: 10.1093/molehr/6.9.811 10956553 

  63. 63 Wang Q. , et al ., Transient exposure to elevated glucose levels causes persistent changes in dermal microvascular endothelial cell responses to injury . Ann Transl Med , 2021 . 9 ( 9 ): p. 758 . doi: 10.21037/atm-20-7617 34268371 

  64. 64 Su Y. , et al ., FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression . J Cancer Res Clin Oncol , 2021 . doi: 10.1007/s00432-021-03730-3 34258652 

  65. 65 Liu X. , et al ., HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer . Exp Mol Pathol , 2021 . 121 : p. 104665 . doi: 10.1016/j.yexmp.2021.104665 34216584 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로